Management of Hepatitis B Infection
Summary
- Adding peginterferon alfa-2a to entecavir treatment results in longer off-treatment sustained responses compared with entecavir monotherapy for HBeAg-positive[Brouwer 2015] but not HBeAg-negative[Bourlière 2017] disease
- Switch to peginterferon alfa-2a following entecavir therapy has also shown some benefit[Ning 2014]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Hepatitis B, Hepatitis B-Treatment